Brooks Laboratories Ltd Share Price
(BROOKS)
₹130
as on 11:30AM, 30 Apr 2025
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 20.94 % |
3 Month Return | -11.7 % |
1 Year Return | + 27.93 % |
Market Stats | |
Previous Close | ₹133.94 |
Open | ₹130.00 |
Volume | 4,775.00 |
Upper Circuit | ₹140.63 |
Lower Circuit | ₹127.24 |
Market Cap | ₹394.55Cr |
P/E Ratio
-16.81
PEG Ratio
7.2
Market Cap
₹394.55 Cr
P/B Ratio
3.5
EPS
-7.46
Dividend Yield
0Sector
Pharmaceuticals
ROE
1.9
Funds | Holdings | Prev. 5M |
---|---|---|
![]() | 2.51% |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 3 quarters, 18.0 Cr → 38.55 Cr (in ₹), with an average increase of 29.9% per quarter
Price Rise
In the last 1 month, BROOKS stock has moved up by 20.9%
FII Holding Up
Foreign Institutions have increased holdings from 0.00% to 0.05% in Mar 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 138.0% return, outperforming this stock by 87.1%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 52.6% return, outperforming this stock by 24.7%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 52.62% of holdings in Mar 2025 quarter
Profit Down
Netprofit is down for the last 3 quarters, -2.41 Cr → -4.57 Cr (in ₹), with an average decrease of 39.9% per quarter
Retail Holding Down
Retail Investor have decreased holdings from 37.48% to 36.95% in Mar 2025 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 52.62% | 0.00 | |
Foreign Institutions | 0.05% | 1907.41 | |
Mutual Funds | 9.9% | 0.00 | |
Retail Investors | 36.95% | ||
Others | 0.48% | 0.00 |
Brooks Laboratories Ltd in the last 5 years
Lowest (-31.36x)
January 11, 2024
Today (-16.81x)
April 29, 2025
Industry (54.77x)
April 29, 2025
Highest (-5.43x)
May 25, 2023
Brooks Laboratories Ltd’s net profit fell -17.78% since last year same period to ₹-4.57Cr in the Q3 2024-2025. On a quarterly growth basis, Brooks Laboratories Ltd has generated -15.4% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Brooks Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹394.55 Cr | 56.21% | 0.55 | -₹20 Cr | ₹79 Cr | |
NA | ₹147.07 Cr | 35.43% | 0.62 | NA | NA | |
NA | ₹5,411.31 Cr | 432.02% | 0.50 | ₹33 Cr | ₹204 Cr | |
NA | ₹1,510.04 Cr | 381.87% | 0.52 | NA | NA | |
NA | ₹3,596.41 Cr | 157.18% | 0.51 | NA | NA |
Organisation | Brooks Laboratories Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Brooks Laboratories Ltd share price today stands at ₹130, Open: ₹130, Previous Close: ₹133.94, High: ₹136.65, Low: ₹130, 52 Week High: ₹198.86, 52 Week Low: ₹73.25.
Today's traded volume of Brooks Laboratories Ltd(BROOKS) is 4,775.00.
Today's market capitalisation of Brooks Laboratories Ltd(BROOKS) is ₹394.55Cr.
Brooks Laboratories Ltd (BROOKS) share price is ₹130. It is down -34.63% from its 52 Week High price of ₹198.86
Brooks Laboratories Ltd (BROOKS) share price is ₹130. It is up 77.47% from its 52 Week Low price of ₹73.25